1 Min Read
April 4 (Reuters) - Immunomedics Inc:
* Immunomedics reports immu-132 delivers high levels of sn-38 that overcome chemoresistant tumors with moderate to strong trop-2 expression Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.